CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 14.53
  • -0.11-0.75%
Trading Oct 16 09:32 CST
4.07BMarket Cap23.03P/E (TTM)

Newland Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
28.60%295.41M
25.69%240.53M
428.07%270.02M
626.83%259.7M
674.96%229.71M
--191.38M
49.46%51.13M
--35.73M
-24.63%29.64M
----
Transactional financial assets
-10.18%504.07M
6.74%620.07M
-15.95%589.5M
10,488.60%530.4M
9,141.65%561.23M
--580.93M
7,993.06%701.36M
--5.01M
-36.32%6.07M
----
Notes receivable and accounts receivable
16.68%293.48M
-21.71%241.07M
-33.25%177.99M
8.00%230.01M
-15.36%251.51M
--307.91M
17.31%266.65M
--212.98M
36.65%297.15M
----
-Notes receivable
5.26%140.93M
-38.30%120.53M
-21.16%68.99M
68.03%106.45M
71.37%133.89M
--195.36M
14.84%87.51M
--63.35M
-22.62%78.13M
----
-Accounts receivable
29.68%152.54M
7.10%120.54M
-39.16%109M
-17.42%123.56M
-46.29%117.63M
--112.55M
18.55%179.15M
--149.63M
88.01%219.02M
----
Other receivables (including interest and dividends)
-62.11%109.73K
-57.41%195.22K
-26.30%189.67K
81.47%253.44K
238.35%289.58K
--458.35K
61.38%257.36K
--139.65K
-75.29%85.58K
----
-Other receivable
-62.11%109.73K
----
-26.30%189.67K
----
238.35%289.58K
----
61.38%257.36K
--139.65K
-75.29%85.58K
----
Advance payment
-27.82%2.7M
187.65%8.96M
732.44%19.65M
158.46%8.81M
67.39%3.74M
--3.12M
81.73%2.36M
--3.41M
41.00%2.23M
----
Inventories
34.62%30.98M
-1.57%34.44M
-42.07%31M
-56.60%27.48M
-46.52%23.01M
--34.99M
-31.88%53.52M
--63.33M
-34.29%43.03M
----
Receivable financing
-28.99%74.08M
-23.62%91.04M
-32.93%62.91M
-14.36%136.37M
18.36%104.33M
--119.19M
121.85%93.8M
--159.23M
77.47%88.15M
----
Other current assets
326.93%5.72M
-52.52%6.48M
-70.07%5.39M
-66.97%4.82M
-87.81%1.34M
--13.65M
112.08%18.02M
--14.61M
283.83%10.99M
----
Total current assets
2.67%1.21B
-0.71%1.24B
-2.57%1.16B
142.26%1.2B
146.19%1.18B
--1.25B
196.03%1.19B
--494.44M
23.58%477.35M
----
Non Current assets
Fixed assets
15.72%289.63M
----
18.72%278.49M
----
25.15%250.29M
----
21.77%234.58M
--199.64M
4.45%199.99M
----
Constru in process
154.82%189.39M
----
92.78%106.7M
----
182.47%74.32M
----
67.64%55.35M
--32.62M
-1.45%26.31M
----
Intangible assets
-2.55%37.45M
-1.88%37.77M
-1.78%38.08M
-1.42%38.44M
-2.13%38.43M
--38.49M
-2.35%38.77M
--38.99M
-2.41%39.27M
----
Long deferred expense
-31.66%4.5M
331.38%5.06M
334.03%5.61M
327.03%6.04M
--6.58M
--1.17M
--1.29M
--1.41M
----
----
Deferred tax assets
----
----
----
----
----
----
----
----
-78.01%162.85K
----
Usufruct assets
-56.54%2.06M
-45.77%2.68M
-46.06%3.01M
-25.79%3.65M
-12.73%4.75M
--4.93M
--5.59M
--4.91M
--5.44M
----
Other non current assets
-14.92%8.08M
15.11%13.69M
89.15%20.96M
-79.77%4.52M
-30.15%9.5M
--11.9M
2,074.13%11.08M
--22.33M
1,669.44%13.6M
----
Total non current assets
38.36%531.11M
34.41%482.77M
30.63%452.86M
31.67%394.89M
34.80%383.87M
--359.17M
29.89%346.66M
--299.91M
9.56%284.77M
----
Total assets
11.46%1.74B
7.13%1.73B
4.94%1.61B
100.51%1.59B
104.57%1.56B
113.10%1.61B
129.64%1.53B
--794.35M
17.94%762.12M
--755.88M
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
----
--93.04M
4.76%88.55M
----
Notes payable and accounts payable
36.24%152.64M
-8.55%124.83M
-17.50%87.75M
4.54%107.08M
12.37%112.04M
--136.51M
32.54%106.37M
--102.43M
12.21%99.71M
----
-Notes payable
----
----
----
----
----
--2.99M
119.46%11.31M
--7.86M
523.60%15.84M
----
-Accounts payable
36.24%152.64M
-6.51%124.83M
-7.69%87.75M
13.23%107.08M
33.59%112.04M
--133.52M
26.58%95.07M
--94.57M
-2.84%83.86M
----
Contract liabilities
-44.58%1.51M
-15.79%4.64M
-3.92%4.43M
-26.55%5.6M
-51.91%2.73M
--5.5M
174.46%4.61M
--7.63M
-26.14%5.68M
----
Salaries payable
24.91%16.16M
23.33%14.39M
22.06%17.27M
3.90%14.09M
22.58%12.93M
--11.66M
10.05%14.15M
--13.56M
6.04%10.55M
----
Taxs payable
-1.94%4.72M
-68.44%3.14M
56.99%1.42M
65.41%5.65M
-24.29%4.82M
--9.94M
-93.13%903.6K
--3.41M
-29.29%6.36M
----
Other payable (including interest and dividends)
49.91%35.27M
22.49%25.77M
-1.91%26.03M
25.86%17.64M
70.14%23.53M
--21.04M
61.49%26.54M
--14.02M
-68.89%13.83M
----
-Other payable
49.91%35.27M
----
-1.91%26.03M
----
70.14%23.53M
----
61.49%26.54M
--14.02M
-68.89%13.83M
----
Non current liabilities due within one year
-37.35%1.56M
-26.90%1.87M
-29.89%1.99M
-80.10%2.51M
-78.05%2.49M
--2.56M
-39.06%2.84M
--12.63M
386.66%11.36M
----
Other current liabilities
-44.58%196.89K
-15.79%602.63K
-3.92%575.87K
-78.08%217.31K
-51.91%355.27K
--715.64K
174.46%599.34K
--991.39K
-26.14%738.74K
----
Total current liabilities
33.46%212.06M
-6.76%175.24M
-10.60%139.47M
-38.32%152.79M
-32.89%158.89M
--187.94M
-29.27%156.01M
--247.7M
-4.46%236.77M
----
Current liabilities
Long term loan
----
----
----
----
----
----
----
--34.66M
-3.19%31.68M
----
Deferred tax liabilities
279.51%9.45M
120.58%9.44M
81.41%9.78M
912.58%2.21M
--2.49M
--4.28M
--5.39M
--218.64K
----
----
Long term deferred income
241.31%34.71M
239.79%34.78M
-2.50%10.04M
-2.48%10.11M
-2.47%10.17M
--10.23M
-2.44%10.3M
--10.36M
-2.41%10.43M
----
Lease liabilities
-89.59%138.43K
-77.50%496.43K
-74.75%727.44K
-71.22%687.36K
-54.74%1.33M
--2.21M
--2.88M
--2.39M
--2.94M
----
Total non current liabilities
216.65%44.3M
167.42%44.71M
10.64%20.54M
-72.69%13.01M
-68.94%13.99M
--16.72M
-54.65%18.57M
--47.63M
3.77%45.04M
----
Total liabilities
48.29%256.36M
7.47%219.95M
-8.34%160.02M
-43.86%165.79M
-38.65%172.88M
--204.66M
-33.24%174.58M
--295.33M
-3.23%281.82M
----
Shareholders equity
Paid-in capital
40.00%280.06M
50.00%200.04M
50.00%200.04M
100.04%200.04M
100.04%200.04M
--133.36M
33.36%133.36M
--100M
0.00%100M
----
Capital reserve funds
-11.04%644.77M
-8.42%724.78M
-8.42%724.78M
8,665.88%724.78M
9,773.01%724.78M
--791.46M
14,325.11%791.46M
--8.27M
102.10%7.34M
----
Surplus reserve funds
26.67%92.91M
30.31%86.89M
27.14%80.84M
55.77%77.89M
46.70%73.35M
--66.68M
27.17%63.58M
--50M
0.00%50M
----
Retained profit
20.39%455.66M
20.08%486.11M
20.78%436.25M
25.66%416.9M
20.51%378.47M
--404.83M
48.96%361.2M
--331.78M
62.22%314.07M
----
Specific reserves
9.94%7.44M
0.81%6.85M
-3.53%6.11M
-7.90%5.11M
27.19%6.76M
--6.79M
38.82%6.33M
--5.55M
42.86%5.32M
----
Shareholders equity without minority interests
7.04%1.48B
7.24%1.5B
6.79%1.45B
187.48%1.42B
190.19%1.38B
220.24%1.4B
236.85%1.36B
--495.59M
35.84%476.73M
--438.15M
Minority interests
-82.78%471.6K
-68.80%941.01K
-54.71%1.47M
-35.21%2.22M
-23.34%2.74M
--3.02M
-15.52%3.25M
--3.43M
-10.63%3.57M
----
Total shareholder equity
6.86%1.48B
7.07%1.51B
6.64%1.45B
185.95%1.43B
188.60%1.39B
--1.41B
234.47%1.36B
--499.02M
35.31%480.3M
----
Total liabilityies and equity
11.46%1.74B
7.13%1.73B
4.94%1.61B
100.51%1.59B
104.57%1.56B
113.10%1.61B
129.64%1.53B
--794.35M
17.94%762.12M
--755.88M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 28.60%295.41M25.69%240.53M428.07%270.02M626.83%259.7M674.96%229.71M--191.38M49.46%51.13M--35.73M-24.63%29.64M----
Transactional financial assets -10.18%504.07M6.74%620.07M-15.95%589.5M10,488.60%530.4M9,141.65%561.23M--580.93M7,993.06%701.36M--5.01M-36.32%6.07M----
Notes receivable and accounts receivable 16.68%293.48M-21.71%241.07M-33.25%177.99M8.00%230.01M-15.36%251.51M--307.91M17.31%266.65M--212.98M36.65%297.15M----
-Notes receivable 5.26%140.93M-38.30%120.53M-21.16%68.99M68.03%106.45M71.37%133.89M--195.36M14.84%87.51M--63.35M-22.62%78.13M----
-Accounts receivable 29.68%152.54M7.10%120.54M-39.16%109M-17.42%123.56M-46.29%117.63M--112.55M18.55%179.15M--149.63M88.01%219.02M----
Other receivables (including interest and dividends) -62.11%109.73K-57.41%195.22K-26.30%189.67K81.47%253.44K238.35%289.58K--458.35K61.38%257.36K--139.65K-75.29%85.58K----
-Other receivable -62.11%109.73K-----26.30%189.67K----238.35%289.58K----61.38%257.36K--139.65K-75.29%85.58K----
Advance payment -27.82%2.7M187.65%8.96M732.44%19.65M158.46%8.81M67.39%3.74M--3.12M81.73%2.36M--3.41M41.00%2.23M----
Inventories 34.62%30.98M-1.57%34.44M-42.07%31M-56.60%27.48M-46.52%23.01M--34.99M-31.88%53.52M--63.33M-34.29%43.03M----
Receivable financing -28.99%74.08M-23.62%91.04M-32.93%62.91M-14.36%136.37M18.36%104.33M--119.19M121.85%93.8M--159.23M77.47%88.15M----
Other current assets 326.93%5.72M-52.52%6.48M-70.07%5.39M-66.97%4.82M-87.81%1.34M--13.65M112.08%18.02M--14.61M283.83%10.99M----
Total current assets 2.67%1.21B-0.71%1.24B-2.57%1.16B142.26%1.2B146.19%1.18B--1.25B196.03%1.19B--494.44M23.58%477.35M----
Non Current assets
Fixed assets 15.72%289.63M----18.72%278.49M----25.15%250.29M----21.77%234.58M--199.64M4.45%199.99M----
Constru in process 154.82%189.39M----92.78%106.7M----182.47%74.32M----67.64%55.35M--32.62M-1.45%26.31M----
Intangible assets -2.55%37.45M-1.88%37.77M-1.78%38.08M-1.42%38.44M-2.13%38.43M--38.49M-2.35%38.77M--38.99M-2.41%39.27M----
Long deferred expense -31.66%4.5M331.38%5.06M334.03%5.61M327.03%6.04M--6.58M--1.17M--1.29M--1.41M--------
Deferred tax assets ---------------------------------78.01%162.85K----
Usufruct assets -56.54%2.06M-45.77%2.68M-46.06%3.01M-25.79%3.65M-12.73%4.75M--4.93M--5.59M--4.91M--5.44M----
Other non current assets -14.92%8.08M15.11%13.69M89.15%20.96M-79.77%4.52M-30.15%9.5M--11.9M2,074.13%11.08M--22.33M1,669.44%13.6M----
Total non current assets 38.36%531.11M34.41%482.77M30.63%452.86M31.67%394.89M34.80%383.87M--359.17M29.89%346.66M--299.91M9.56%284.77M----
Total assets 11.46%1.74B7.13%1.73B4.94%1.61B100.51%1.59B104.57%1.56B113.10%1.61B129.64%1.53B--794.35M17.94%762.12M--755.88M
Liabilities
Current liabilities
Short term loan ------------------------------93.04M4.76%88.55M----
Notes payable and accounts payable 36.24%152.64M-8.55%124.83M-17.50%87.75M4.54%107.08M12.37%112.04M--136.51M32.54%106.37M--102.43M12.21%99.71M----
-Notes payable ----------------------2.99M119.46%11.31M--7.86M523.60%15.84M----
-Accounts payable 36.24%152.64M-6.51%124.83M-7.69%87.75M13.23%107.08M33.59%112.04M--133.52M26.58%95.07M--94.57M-2.84%83.86M----
Contract liabilities -44.58%1.51M-15.79%4.64M-3.92%4.43M-26.55%5.6M-51.91%2.73M--5.5M174.46%4.61M--7.63M-26.14%5.68M----
Salaries payable 24.91%16.16M23.33%14.39M22.06%17.27M3.90%14.09M22.58%12.93M--11.66M10.05%14.15M--13.56M6.04%10.55M----
Taxs payable -1.94%4.72M-68.44%3.14M56.99%1.42M65.41%5.65M-24.29%4.82M--9.94M-93.13%903.6K--3.41M-29.29%6.36M----
Other payable (including interest and dividends) 49.91%35.27M22.49%25.77M-1.91%26.03M25.86%17.64M70.14%23.53M--21.04M61.49%26.54M--14.02M-68.89%13.83M----
-Other payable 49.91%35.27M-----1.91%26.03M----70.14%23.53M----61.49%26.54M--14.02M-68.89%13.83M----
Non current liabilities due within one year -37.35%1.56M-26.90%1.87M-29.89%1.99M-80.10%2.51M-78.05%2.49M--2.56M-39.06%2.84M--12.63M386.66%11.36M----
Other current liabilities -44.58%196.89K-15.79%602.63K-3.92%575.87K-78.08%217.31K-51.91%355.27K--715.64K174.46%599.34K--991.39K-26.14%738.74K----
Total current liabilities 33.46%212.06M-6.76%175.24M-10.60%139.47M-38.32%152.79M-32.89%158.89M--187.94M-29.27%156.01M--247.7M-4.46%236.77M----
Current liabilities
Long term loan ------------------------------34.66M-3.19%31.68M----
Deferred tax liabilities 279.51%9.45M120.58%9.44M81.41%9.78M912.58%2.21M--2.49M--4.28M--5.39M--218.64K--------
Long term deferred income 241.31%34.71M239.79%34.78M-2.50%10.04M-2.48%10.11M-2.47%10.17M--10.23M-2.44%10.3M--10.36M-2.41%10.43M----
Lease liabilities -89.59%138.43K-77.50%496.43K-74.75%727.44K-71.22%687.36K-54.74%1.33M--2.21M--2.88M--2.39M--2.94M----
Total non current liabilities 216.65%44.3M167.42%44.71M10.64%20.54M-72.69%13.01M-68.94%13.99M--16.72M-54.65%18.57M--47.63M3.77%45.04M----
Total liabilities 48.29%256.36M7.47%219.95M-8.34%160.02M-43.86%165.79M-38.65%172.88M--204.66M-33.24%174.58M--295.33M-3.23%281.82M----
Shareholders equity
Paid-in capital 40.00%280.06M50.00%200.04M50.00%200.04M100.04%200.04M100.04%200.04M--133.36M33.36%133.36M--100M0.00%100M----
Capital reserve funds -11.04%644.77M-8.42%724.78M-8.42%724.78M8,665.88%724.78M9,773.01%724.78M--791.46M14,325.11%791.46M--8.27M102.10%7.34M----
Surplus reserve funds 26.67%92.91M30.31%86.89M27.14%80.84M55.77%77.89M46.70%73.35M--66.68M27.17%63.58M--50M0.00%50M----
Retained profit 20.39%455.66M20.08%486.11M20.78%436.25M25.66%416.9M20.51%378.47M--404.83M48.96%361.2M--331.78M62.22%314.07M----
Specific reserves 9.94%7.44M0.81%6.85M-3.53%6.11M-7.90%5.11M27.19%6.76M--6.79M38.82%6.33M--5.55M42.86%5.32M----
Shareholders equity without minority interests 7.04%1.48B7.24%1.5B6.79%1.45B187.48%1.42B190.19%1.38B220.24%1.4B236.85%1.36B--495.59M35.84%476.73M--438.15M
Minority interests -82.78%471.6K-68.80%941.01K-54.71%1.47M-35.21%2.22M-23.34%2.74M--3.02M-15.52%3.25M--3.43M-10.63%3.57M----
Total shareholder equity 6.86%1.48B7.07%1.51B6.64%1.45B185.95%1.43B188.60%1.39B--1.41B234.47%1.36B--499.02M35.31%480.3M----
Total liabilityies and equity 11.46%1.74B7.13%1.73B4.94%1.61B100.51%1.59B104.57%1.56B113.10%1.61B129.64%1.53B--794.35M17.94%762.12M--755.88M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data